Comparison of Osteoporosis Disease Management Strategies (0000-039)

The purpose of this study is to assess the impact of disease management interventions on bone mineral density screening rates and osteoporosis treatment rates in women age 50-64 years at high risk for osteoporosis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Osteoporosis Bone Diseases Bone Diseases, Metabolic Metabolic Diseases Musculoskeletal Diseases Nutritional and Metabolic Diseases

Age range

50 year–64 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Members of the Harvard Pilgrim Health Plan

Exclusion criteria

Individuals who are not members of the Harvard Pilgrim Health Plan

Treatment and study plan

Disease Management Assessment

Behavioral

Primary outcomes

Bone mineral density screening rates

Secondary outcomes

Medications adoptions; Medications adherence

Sponsors and collaborators

Lead sponsor

Merck Sharp & Dohme LLC

Industry

Registry information

Official study title

Evaluation of Strategies for Increasing Osteoporosis Screening and Treatment in a Managed Care Organization

Important dates

Study start: 2004
Primary completion: 2006
Study completion: 2006
First posted: Sep 5, 2005
Registry last updated: Nov 2, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed